Skip to main content
SpringerLink
Log in

Posttherapeutic Magnetic Resonance Imaging

  • Chapter
Breast MRI

  • 1700 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Feldman L, Hortobagyi GN, Buzdar AU, et al. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res. 1986;46:2578–2581.

    PubMed  CAS  Google Scholar 

  2. Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol. 1998;16:93–100.

    PubMed  CAS  Google Scholar 

  3. Esserman L, Kaplan E, Partridge S, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in Stage III breast cancer. Ann Surg Oncol. 2001;8:549–559.

    PubMed  CAS  Google Scholar 

  4. Hortobagyi G, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507–2516.

    CAS  Google Scholar 

  5. Kuerer HM, Newman LA, Buzdar AU, et al. Residual metastatic axillary lymph nodes following neoadjuvant cxhemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg. 1998;176: 502–509.

    Article  PubMed  CAS  Google Scholar 

  6. Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicinbased neoadjuvant therapy. J Clin Oncol. 1999;17:460–469.

    PubMed  CAS  Google Scholar 

  7. Balu-Maestro C, Chapellier C, Bleuse A, et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat. 2002;72:145–152.

    Article  PubMed  CAS  Google Scholar 

  8. Minckwitz GV, Costa SD, Eiermann W, et al. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol. 1999;17:1999–2005.

    Google Scholar 

  9. Dershaw DD, Drossman S, Liberman L, Abramson AF. Assessment of response to therapy of primary breast cancer by mammography and physical examination. Cancer 1995;75:2093–2098.

    PubMed  CAS  Google Scholar 

  10. Partridge SC, Gibbs JE, Lu Y, et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002;179:1193–1199.

    PubMed  Google Scholar 

  11. Mumtaz H, Davidson T, Spittle M, et al. Breast surgery after neoadjuvant treatment. Is it necessary? Eur J Surg Oncol. 1996;22:335–341.

    Article  PubMed  CAS  Google Scholar 

  12. Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of respose to induction chemotherapy. Radiology 1988;169:49–54.

    PubMed  CAS  Google Scholar 

  13. Vinnicombe SJ, Macvicar AD, Guy RL, et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 1996;198: 333–340.

    PubMed  CAS  Google Scholar 

  14. Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633–638.

    PubMed  CAS  Google Scholar 

  15. Herrada J, Iyer RB, Atkinson EN, et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjiuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res. 1997;3:1565–1569.

    PubMed  CAS  Google Scholar 

  16. Wasser K, Sinn HP, Fink C, et al. Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol [serial online]., 2002;13:1213–1223. Available at: http://link.springer.de/link/service/journals/00330/contents/02/01730/paper/s00330-002-1730. Accessed 09/05/ 2004.

    Google Scholar 

  17. Abraham DC, Jones RC, Jones SE, et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996;78:91–100.

    Article  PubMed  CAS  Google Scholar 

  18. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003;226:773–778.

    PubMed  Google Scholar 

  19. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast in women with recently diagnosed breast cancer. AJR Am J Roentgenol. 2003;180:333–341.

    PubMed  Google Scholar 

  20. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881–888.

    PubMed  CAS  Google Scholar 

  21. Slanetz PJ, Edmister WB, Yeh ED, et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J. 2002;8:145–148.

    Article  PubMed  Google Scholar 

  22. Rieber A, Brambs HJ, Gabelmann A, et al. Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol. 2002;12:1711–1719.

    PubMed  CAS  Google Scholar 

  23. Schelling M, Avril N, Nahrig J, et al. Positron emission tomography using [18F] fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol. 2000;18:1689–1695.

    PubMed  CAS  Google Scholar 

  24. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822–828.

    PubMed  CAS  Google Scholar 

  25. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast conserving surgery and radiotherapy. Cancer 1989;63:1912–1917.

    PubMed  CAS  Google Scholar 

  26. Rieber A, Merkle E, Zeitler H, et al. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr. 1997;21:780–784.

    PubMed  CAS  Google Scholar 

  27. Drew P, Kerin MJ, Turnbull LW, et al. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol. 1998;5:265–270.

    PubMed  CAS  Google Scholar 

  28. Dershaw DD. Mammography in patients with breast cancer treated by breast conservation (lumpectomy with or without radiation). AJR Am J Roentgenol. 1995;164:309–316.

    PubMed  CAS  Google Scholar 

  29. Davis PL, McCarty KS. Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent. Eur Radiol. 1977;7(Suppl 5):S289–S298.

    Google Scholar 

  30. Murray AD, Redpath TW, Needham G, et al. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma. Br J Radiol. 1996;69:594–600.

    PubMed  CAS  Google Scholar 

  31. Gilles R, Guinebretiere J, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993;188:473–478.

    PubMed  CAS  Google Scholar 

  32. Heywang-Kobrunner SH, Schlegel A, Beck R, et al. Contrast enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr. 1993;17:891–900.

    PubMed  CAS  Google Scholar 

  33. Dershaw DD, Shank B, Reisinger S. Mammographic findings after breast cancer treatment with local excision and definitive irradiation. Radiology 1987;164:455–461.

    PubMed  CAS  Google Scholar 

  34. Sickles EA, Filly RA, Callen PW. Breast cancer detection with sonography and mammography: comparison using state-of-the-art equipment. AJR Am J Roentgenol. 1983;140:843–845.

    PubMed  CAS  Google Scholar 

  35. Solomon B, Orel S, Reynolds C, Schnall MD. Delayed development of enhancement in fat necrosis after breast conservation therapy: a potential pitfall of MR imaging of the breast. AJR Am J Roentgenol. 1998;170:966–968.

    PubMed  CAS  Google Scholar 

  36. Lewis-Jones HG, Whitehouse GH, Leinster SJ. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol. 1991;43:197–204.

    PubMed  CAS  Google Scholar 

  37. Kerslake RW, Fox JN, Carleton PJ, et al. Dynamic contrast enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. Br J Radiol. 1994;67:1158–1168.

    PubMed  CAS  Google Scholar 

  38. Dao TH, Rahmouni A, Campana F, et al. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993;187:751–755.

    PubMed  CAS  Google Scholar 

  39. Hickman PF, Moore NR, Shepstone BJ. The indeterminate breast mass: assessment using contrast enhanced magnetic resonance imaging. Br J Radiol. 1994;67:14–20.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, NY

    Jennifer B. Kaplan MD (Clinical Assistant Radiologist) & D. David Dershaw MD, FACR (Director, Attending Radiologist)

  2. Weill Medical College at Cornell University, New York, NY, 10021, USA

    Jennifer B. Kaplan MD (Clinical Assistant Radiologist)

  3. Department of Radiology, Weill Medical College of Cornell University, New York, NY, 10021, USA

    D. David Dershaw MD, FACR (Director, Attending Radiologist)

Authors
  1. Jennifer B. Kaplan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. David Dershaw MD, FACR
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Kaplan, J.B., Dershaw, D.D. (2005). Posttherapeutic Magnetic Resonance Imaging. In: Breast MRI. Springer, New York, NY. https://doi.org/10.1007/0-387-27595-9_14

Download citation

  • DOI: https://doi.org/10.1007/0-387-27595-9_14

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-21997-4

  • Online ISBN: 978-0-387-27595-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation